Skip to content
Governance Register
Sign inFind yourself
Find yourselfSign in
Search How it works For organisations For professionals

Edition

United KingdomIrelandUnited States (current)New ZealandCanadaAustraliaScotlandNorthern Ireland

← US public companies

Lorianne Masuoka K.

SEC-identified person · CIK 1466086 Identifier-verified

Public-company roles (from insider filings)

CompanyCapacity as filedFilings
Diamedica Therapeutics Inc. DMAX Chief Medical Officer filed 2024 - 2024
Opiant Pharmaceuticals, INC. OPNT Director filed 2021 - 2023
Marinus Pharmaceuticals, INC. NASDAQMRNS Chief Medical Officer filed 2017 - 2019
Invivo Therapeutics Holdings Corp. None Chief Medical Officer filed 2015 - 2016
Nektar Therapeutics NKTR SVP & Chief Medical Officer filed 2009 - 2011

All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.